2.50Open2.50Pre Close0 Volume125 Open Interest22.50Strike Price0.00Turnover1725.17%IV3.75%PremiumJul 19, 2024Expiry Date1.72Intrinsic Value100Multiplier0DDays to Expiry0.78Extrinsic Value100Contract SizeAmericanOptions Type-0.6464Delta0.1039Gamma8.31Leverage Ratio-18.6628Theta0.0000Rho-5.37Eff Leverage0.0008Vega
Nurix Therapeutics Stock Discussion
as this guy 👇
$Taysha Gene Therapies(TSHA.US)$ 21% FY 2023 results
$TFF Pharmaceuticals(TFFP.US)$ 14% Clinical programs update
$Jaguar Health(JAGX.US)$ 14% Crofelemer commercialization
$Acelyrin(SLRN.US)$ 4% Ph1/2 positive data
$Delcath Systems(DCTH.US)$ 3% Closes $7M private placement
$Sellas Life Sciences(SLS.US)$ 0% Closes $20M offering & private placement
$Immunic(IMUX.US)$ 1% Patent notice of allowance
$Nurix Therapeutics(NRIX.US)$ 0...
Nurix said patients currently enrolled in the trial who are deriving clinical benefit are allowed to continue receiving the current drug product. The screening and enrollment of new patients has been paused.
The company sai...
No comment yet